ArticleFrontiers in immunology2021

Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease.

Dong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.